Directory Last Updated: 20 November 2024
Return to Directory Key Opinion Leaders in Clinical Trials Areas - word selected:- SCLERODERMA
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
Page No 1
PhraseConsultantTownSpecial Interests
Scleroderma
*Consultant(s)*
*Towns*Scleroderma, Raynaud's
scleroderma
*Consultant(s)*
*Towns*Paediatric rheumatology, juvenile rheumatoid arthritis, Raynaud's syndrome, scleroderma, childhood systemic lupus erythematosus - SLE, steroid induced osteoporosis in childhood, hypermobility, chronic pain
scleroderma
*Consultant(s)*
*Towns*Experimental rheumatology, scleroderma, Raynaud's phenomenon
scleroderma
*Consultant(s)*
*Towns*Immunotherapy, rheumatoid arthritis, connective tissue disorders, systemic lupus erythematosus - SLE, pain, ankylosing spondylitis, scleroderma
scleroderma
*Consultant(s)*
*Towns*Rheumatology, osteoporosis, vasculitis, connective tissue disease, scleroderma, spondyloarthropathy, education
scleroderma
*Consultant(s)*
*Towns*Morphoea, systemic lupus erythematosus - SLE, scleroderma, Fabry's disease, overlap connective tissue diseases
Scleroderma
*Consultant(s)*
*Towns*Scleroderma, Raynaud's, rheumatoid arthritis
scleroderma
*Consultant(s)*
*Towns*Raynaud's disease, scleroderma, sports injury, rheumatoid arthritis, Sjogren's syndrome
scleroderma kidney disease
*Consultant(s)*
*Towns*Vasculitis, acute nephritis, systemic lupus erythematosus - SLE, CKD - chronic kidney disease, end of life care for renal patients, scleroderma kidney disease
Page No 1
Spacer

Third Party Advertisement

Adverts by Google